Characterization of disease-associated N-linked glycoproteins

Proteomics

Volumn 13, Issue 3-4, 2013, Pages 504-511

  Tian, Yuan ^a   Zhang, Hui ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Disease association; Glycoproteomics; N linked glycoproteins

Indexed keywords

BIOLOGICAL MARKER; BORONIC ACID DERIVATIVE; GLYCOPROTEIN; HYDRAZIDE; SUGAR;

BREAST CANCER; CHROMATOGRAPHY; DISEASE ASSOCIATION; GLYCOSYLATION; HUMAN; LECTIN AFFINITY CHROMATOGRAPHY; LUNG CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEOMICS; REVIEW;

CHROMATOGRAPHY, LIQUID; GLYCOPROTEINS; GLYCOSYLATION; HUMANS; NEOPLASMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOMICS; TUMOR MARKERS, BIOLOGICAL;

EID: 84873948403     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201200333     Document Type: Review

References (85)

1. Furukawa, K., Kobata, A., Protein glycosylation. Curr. Opin. Biotechnol. 1992, 3, 554-559.
2. Varki, A., Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 1993, 3, 97-130.
3. Tian, Y., Zhang, H., Glycoproteomics and clinical applications. Proteomics Clin. Appl. 2010, 4, 124-132.
4. Kay Li, Q., Gabrielson, E., Zhang, H., Application of glycoproteomics for the discovery of biomarkers in lung cancer. Proteomics Clin. Appl. 2012, 6, 244-256.
5. Peracaula, R., Barrabes, S., Sarrats, A., Rudd, P. M., de Llorens, R., Altered glycosylation in tumours focused to cancer diagnosis. Dis. Markers 2008, 25, 207-218.
6. Drake, R. R., Schwegler, E. E., Malik, G., Diaz, J. et al., Lectin capture strategies combined with mass spectrometry for the discovery of serum glycoprotein biomarkers. Mol. Cell. Proteomics 2006, 5, 1957-1967.
7. Gebauer, G., Muller-Ruchholtz, W., Tumor marker concentrations in normal and malignant tissues of colorectal cancer patients and their prognostic relevance. Anticancer Res. 1997, 17, 2939-2942.
8. Catalona, W. J., Smith, D. S., Ratliff, T. L., Dodds, K. M. et al., Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. New Engl. J. Med. 1991, 324, 1156-1161.
9. Zhou, L., Liu, J., Luo, F., Serum tumor markers for detection of hepatocellular carcinoma. World J. Gastroentero. 2006, 12, 1175-1181.
10. Seregni, E., Massimino, M., Nerini Molteni, S., Pallotti, F. et al., Serum and cerebrospinal fluid human chorionic gonadotropin (hCG) and alpha-fetoprotein (AFP) in intracranial germ cell tumors. Int. J. Biol. Marker. 2002, 17, 112-118.
11. Grigorian, A., Torossian, S., Demetriou, M., T-cell growth, cell surface organization, and the galectin-glycoprotein lattice. Immunol. Rev. 2009, 230, 232-246.
12. Simonds, H. M., Miles, D., Adjuvant treatment of breast cancer: impact of monoclonal antibody therapy directed against the HER2 receptor. Expert Opin. Biol. Ther. 2007, 7, 487-491.
13. Cummings, R. D., Kornfeld, S., Fractionation of asparagine-linked oligosaccharides by serial lectin-Agarose affinity chromatography. A rapid, sensitive, and specific technique. J. Biol. Chem. 1982, 257, 11235-11240.
14. Wu, A. M., Song, S. C., Tsai, M. S., Herp, A., A guide to the carbohydrate specificities of applied lectins-2 (updated in 2000). Adv. Exp. Med. Biol. 2001, 491, 551-585.
15. Rudiger, H., Gabius, H. J., Plant lectins: occurrence, biochemistry, functions and applications. Glycoconj. J. 2001, 18, 589-613.
16. Hirabayashi, J., Lectin-based structural glycomics: glycoproteomics and glycan profiling. Glycoconj. J. 2004, 21, 35-40.
17. Dai, Z., Zhou, J., Qiu, S. J., Liu, Y. K. et al., Lectin-based glycoproteomics to explore and analyze hepatocellular carcinoma-related glycoprotein markers. Electrophoresis 2009, 30, 2957-2966.
18. Jung, K., Cho, W., Regnier, F. E., Glycoproteomics of plasma based on narrow selectivity lectin affinity chromatography. J. Proteome. Res. 2009, 8, 643-650.
19. Madera, M., Mechref, Y., Klouckova, I., Novotny, M. V., High-sensitivity profiling of glycoproteins from human blood serum through multiple-lectin affinity chromatography and liquid chromatography/tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2007, 845, 121-137.
20. Ueda, K., Takami, S., Saichi, N., Daigo, Y. et al., Development of serum glycoproteomic profiling technique; simultaneous identification of glycosylation sites and site-specific quantification of glycan structure changes. Mol. Cell. Proteomics 2010, 9, 1819-1828.
21. Zhang, H., Li, X. J., Martin, D. B., Aebersold, R., Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nat. Biotechnol. 2003, 21, 660-666.
22. Tian, Y., Yao, Z., Roden, R. B., Zhang, H., Identification of glycoproteins associated with different histological subtypes of ovarian tumors using quantitative glycoproteomics. Proteomics 2011, 11, 4677-4687.
23. Tian, Y., Bova, G. S., Zhang, H., Quantitative glycoproteomic analysis of optimal cutting temperature-embedded frozen tissues identifying glycoproteins associated with aggressive prostate cancer. Anal. Chem. 2011, 83, 7013-7019.
24. Zeng, X., Hood, B. L., Sun, M., Conrads, T. P. et al., Lung cancer serum biomarker discovery using glycoprotein capture and liquid chromatography mass spectrometry. J. Proteome Res. 2010, 9, 6440-6449.
25. Tian, Y., Kelly-Spratt, K. S., Kemp, C. J., Zhang, H., Identification of glycoproteins from mouse skin tumors and plasma. Clin. Proteomics 2008, 4, 117-136.
26. Wollscheid, B., Bausch-Fluck, D., Henderson, C., O'Brien, R. et al., Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins. Nat. Biotechnol. 2009, 27, 378-386.
27. Gundry, R. L., Raginski, K., Tarasova, Y., Tchernyshyov, I. et al., The mouse C2C12 myoblast cell surface N-linked glycoproteome: identification, glycosite occupancy, and membrane orientation. Mol. Cell. Proteomics 2009, 8, 2555-2569.
28. Tian, Y., Esteva, F. J., Song, J., Zhang, H., Altered expression of sialylated glycoproteins in breast cancer using hydrazide chemistry and mass spectrometry. Mol. Cell. Proteomics 2012, 11, M111 011403.
29. Almaraz, R. T., Tian, Y., Bhattarcharya, R., Tan, E. et al., Metabolic flux increases glycoprotein sialylation: implications for cell adhesion and cancer metastasis. Mol. Cell. Proteomics 2012, 11, M112 017558.
30. Nilsson, J., Ruetschi, U., Halim, A., Hesse, C. et al., Enrichment of glycopeptides for glycan structure and attachment site identification. Nat. Methods 2009, 6, 809-811.
31. Chen, R., Tan, Y., Wang, M., Wang, F. et al., Development of glycoprotein capture-based label-free method for the high-throughput screening of differential glycoproteins in hepatocellular carcinoma. Mol. Cell. Proteomics 2011, 10, M110 006445.
32. Hawkins, C. J., Lavin, M. F., Parry, D. L., Ross, I. L., Isolation of 3, 4-dihydroxyphenylalanine-containing proteins using boronate affinity chromatography. Anal. Biochem. 1986, 159, 187-190.
33. Liu, X. C., Scouten, W. H., Boronate affinity chromatography. Methods Mol. Biol. 2000, 147, 119-128.
34. Preinerstorfer, B., Lammerhofer, M., Lindner, W., Synthesis and application of novel phenylboronate affinity materials based on organic polymer particles for selective trapping of glycoproteins. J. Sep. Sci. 2009, 32, 1673-1685.
35. Ren, L., Liu, Y., Dong, M., Liu, Z., Synthesis of hydrophilic boronate affinity monolithic capillary for specific capture of glycoproteins by capillary liquid chromatography. J. Chromatogr. A 2009, 1216, 8421-8425.
36. Suksrichavalit, T., Yoshimatsu, K., Prachayasittikul, V., Bulow, L., Ye, L., "Clickable" affinity ligands for effective separation of glycoproteins. J. Chromatogr. A 2010, 1217, 3635-3641.
37. Saxon, E., Bertozzi, C. R., Cell surface engineering by a modified Staudinger reaction. Science 2000, 287, 2007-2010.
38. Vocadlo, D. J., Hang, H. C., Kim, E. J., Hanover, J. A. et al., A chemical approach for identifying O-GlcNAc-modified proteins in cells. Proc. Natl. Acad. Sci. USA 2003, 100, 9116-9121.
39. Hang, H. C., Yu, C., Kato, D. L., Bertozzi, C. R., A metabolic labeling approach toward proteomic analysis of mucin-type O-linked glycosylation. Proc. Natl. Acad. Sci. USA 2003, 100, 14846-14851.
40. Sawa, M., Hsu, T. L., Itoh, T., Sugiyama, M. et al., Glycoproteomic probes for fluorescent imaging of fucosylated glycans in vivo. Proc. Natl. Acad. Sci. USA 2006, 103, 12371-12376.
41. Mahal, L. K., Yarema, K. J., Bertozzi, C. R., Engineering chemical reactivity on cell surfaces through oligosaccharide biosynthesis. Science 1997, 276, 1125-1128.
42. Sampathkumar, S. G., Li, A. V., Jones, M. B., Sun, Z., Yarema, K. J., Metabolic installation of thiols into sialic acid modulates adhesion and stem cell biology. Nat. Chem. Biol. 2006, 2, 149-152.
43. Bond, M. R., Kohler, J. J., Chemical methods for glycoprotein discovery. Curr. Opin. Chem. Biol. 2007, 11, 52-58.
44. Nilsson, B. L., Kiessling, L. L., Raines, R. T., Staudinger ligation: a peptide from a thioester and azide. Org. Lett. 2000, 2, 1939-1941.
45. Speers, A. E., Cravatt, B. F., Profiling enzyme activities in vivo using click chemistry methods. Chem. Biol. 2004, 11, 535-546.
46. Agard, N. J., Prescher, J. A., Bertozzi, C. R., A strain-promoted [3 + 2] azide-alkyne cycloaddition for covalent modification of biomolecules in living systems. J. Am. Chem. Soc. 2004, 126, 15046-15047.
47. Yang, L., Nyalwidhe, J. O., Guo, S., Drake, R. R., Semmes, O. J., Targeted identification of metastasis-associated cell-surface sialoglycoproteins in prostate cancer. Mol. Cell. Proteomics 2011, 10, M110 007294.
48. Hubbard, S. C., Boyce, M., McVaugh, C. T., Peehl, D. M. et al., Cell surface glycoproteomic analysis of prostate cancer-derived PC-3 cells. Bioorg. Med. Chem. Lett. 2011, 21, 4945-4950.
49. Alvarez-Manilla, G., Atwood, J., 3rd, Guo, Y., Warren, N. L. et al., Tools for glycoproteomic analysis: size exclusion chromatography facilitates identification of tryptic glycopeptides with N-linked glycosylation sites. J. Proteome. Res. 2006, 5, 701-708.
50. Hagglund, P., Bunkenborg, J., Elortza, F., Jensen, O. N. et al., A new strategy for identification of N-glycosylated proteins and unambiguous assignment of their glycosylation sites using HILIC enrichment and partial deglycosylation. J. Proteome. Res. 2004, 3, 556-566.
51. Lam, M. P., Lau, E., Siu, S. O., Ng, D. C. et al., Online combination of reversed-phase/reversed-phase and porous graphitic carbon liquid chromatography for multicomponent separation of proteomics and glycoproteomics samples. Electrophoresis 2011, 32, 2930-2940.
52. Ge, Y., Rajkumar, L., Guzman, R. C., Nandi, S. et al., Multiplexed fluorescence detection of phosphorylation, glycosylation, and total protein in the proteomic analysis of breast cancer refractoriness. Proteomics 2004, 4, 3464-3467.
53. Tian, Y., Bova, G. S., Zhang, H., Quantitative glycoproteomic analysis of optimal cutting temperature-embedded frozen tissues identifying glycoproteins associated with aggressive prostate cancer. Anal. Chem. 2011, 83, 7013-7019.
54. Tian, Y., Yao, Z., Roden, R. B., Zhang, H., Identification of glycoproteins associated with different histological subtypes of ovarian tumors using quantitative glycoproteomics. Proteomics 2011, 11, 4677-4687.
55. Sasaki, T., Brakebusch, C., Engel, J., Timpl, R., Mac-2 binding protein is a cell-adhesive protein of the extracellular matrix which self-assembles into ring-like structures and binds beta1 integrins, collagens and fibronectin. EMBO J. 1998, 17, 1606-1613.
56. Ulmer, T. A., Keeler, V., Andre, S., Gabius, H. J. et al., The tumor-associated antigen 90K/Mac-2-binding protein secreted by human colon carcinoma cells enhances extracellular levels of promatrilysin and is a novel substrate of matrix metalloproteinases-2, -7 (matrilysin) and -9: Implications of proteolytic cleavage. Biochim. Biophys. Acta. 2010, 1800, 336-343.
57. Ruan, K., Bao, S., Ouyang, G., The multifaceted role of periostin in tumorigenesis. Cell. Mol. Life Sci. 2009, 66, 2219-2230.
58. Norris, R. A., Damon, B., Mironov, V., Kasyanov, V. et al., Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissues. J. Cell. Biochem. 2007, 101, 695-711.
59. Takayama, G., Arima, K., Kanaji, T., Toda, S. et al., Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. J. Allergy Clin. Immunol. 2006, 118, 98-104.
60. Peinado, H., Olmeda, D., Cano, A., Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat. Rev. Cancer 2007, 7, 415-428.
61. Thiery, J. P., Sleeman, J. P., Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol. 2006, 7, 131-142.
62. Thiery, J. P., Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2002, 2, 442-454.
63. Soltermann, A., Tischler, V., Arbogast, S., Braun, J. et al., Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer. Clin. Cancer Res. 2008, 14, 7430-7437.
64. Wight, T. N., Versican: a versatile extracellular matrix proteoglycan in cell biology. Curr. Opin. Cell. Biol. 2002, 14, 617-623.
65. Kodama, J., Hasengaowa, Kusumoto, T., Seki, N. et al., Prognostic significance of stromal versican expression in human endometrial cancer. Ann. Oncol. 2007, 18, 269-274.
66. Sasaki, H., Dai, M., Auclair, D., Fukai, I. et al., Serum level of the periostin, a homologue of an insect cell adhesion molecule, as a prognostic marker in nonsmall cell lung carcinomas. Cancer 2001, 92, 843-848.
67. Caplan, A., Kratz, A., Prostate-specific antigen and the early diagnosis of prostate cancer. Am. J. Clin. Pathol. 2002, 117, S104-S108.
68. Borgermann, C., Kliner, S., Swoboda, A., Luboldt, H. J. et al., Parameters to improve the specificity of the prostate-specific antigen. Early detection of prostate cancer. Urologe A 2011, 50, 1095-1100.
69. Block, T. M., Comunale, M. A., Lowman, M., Steel, L. F. et al., Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. Proc. Natl. Acad. Sci. USA 2005, 102, 779-784.
70. Tsai, H. Y., Boonyapranai, K., Sriyam, S., Yu, C. J. et al., Glycoproteomics analysis to identify a glycoform on haptoglobin associated with lung cancer. Proteomics 2011, 11, 2162-2170.
71. Durand, G., Seta, N., Protein glycosylation and diseases: blood and urinary oligosaccharides as markers for diagnosis and therapeutic monitoring. Clin. Chem. 2000, 46, 795-805.
72. Drake, P. M., Cho, W., Li, B., Prakobphol, A. et al., Sweetening the pot: adding glycosylation to the biomarker discovery equation. Clin. Chem. 2010, 56, 223-236.
73. Galonic, D. P., Gin, D. Y., Chemical glycosylation in the synthesis of glycoconjugate antitumour vaccines. Nature 2007, 446, 1000-1007.
74. Lim, K. T., Miyazaki, K., Kimura, N., Izawa, M. et al., Clinical application of functional glycoproteomics - dissection of glycotopes carried by soluble CD44 variants in sera of patients with cancers. Proteomics 2008, 8, 3263-3273.
75. Meany, D. L., Zhang, Z., Sokoll, L. J., Zhang, H. et al., Glycoproteomics for prostate cancer detection: changes in serum PSA glycosylation patterns. J. Proteome. Res. 2009, 8, 613-619.
76. Li, Y., Tao, S. C., Bova, G. S., Liu, A. Y. et al., Detection and verification of glycosylation patterns of glycoproteins from clinical specimens using lectin microarrays and lectin-based immunosorbent assays. Anal. Chem. 2011, 83, 8509-8516.
77. Li, Y., Tian, Y., Rezai, T., Prakash, A. et al., Simultaneous analysis of glycosylated and sialylated prostate-specific antigen revealing differential distribution of glycosylated prostate-specific antigen isoforms in prostate cancer tissues. Anal. Chem. 2011, 83, 240-245.
78. Peracaula, R., Tabares, G., Royle, L., Harvey, D. J. et al., Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins. Glycobiology 2003, 13, 457-470.
79. Zhang, H., Chan, D. W., Cancer biomarker discovery in plasma using a tissue-targeted proteomic approach. Cancer Epidem Biomar 2007, 16, 1915-1917.
80. Tian, Y., Kelly-Spratt, K. S., Kemp, C. J., Zhang, H., Mapping tissue-specific expression of extracellular proteins using systematic glycoproteomic analysis of different mouse tissues. J. Proteome. Res. 2010, 9, 5837-5847.
81. Ishihara, T., Fukuda, I., Morita, A., Takinami, Y. et al., Development of quantitative plasma N-glycoproteomics using label-free 2D LC-MALDI MS and its applicability for biomarker discovery in hepatocellular carcinoma. J. Proteomics 2011, 74, 2159-2168.
82. Zhang, L., Jia, X., Zhang, X., Cao, J. et al., Alpha-1 antitrypsin variants in plasma from HIV-infected patients revealed by proteomic and glycoproteomic analysis. Electrophoresis 2010, 31, 3437-3445.
83. Di Michele, M., Marcone, S., Cicchillitti, L., Della Corte, A. et al., Glycoproteomics of paclitaxel resistance in human epithelial ovarian cancer cell lines: towards the identification of putative biomarkers. J. Proteomics 2010, 73, 879-898.
84. Ueda, K., Takami, S., Saichi, N., Daigo, Y. et al., Development of serum glycoproteomic profiling technique; simultaneous identification of glycosylation sites and site-specific quantification of glycan structure changes. Mol. Cell. Proteomics 2010.
85. Xu, Z., Wu, J., Zha, X., Up-regulation of prohibitin 1 is involved in the proliferation and migration of liver cancer cells. Sci. China Life Sci. 2011, 54, 121-127.